Boston Scientific Global Peripheral Interventions Pi Reporting Unit — Net Sales increased by 0.6% to $702.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 16.6%, from $602.00M to $702.00M. Over 3 years (FY 2021 to FY 2024), Global Peripheral Interventions Pi Reporting Unit — Net Sales shows an upward trend with a 9.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates growing market share or higher clinical demand for the company's peripheral intervention product portfolio, while a decrease may signal increased competition or reduced procedure volumes in this specific medical specialty.
This metric represents the total revenue generated from the sale of medical devices designed for peripheral vascular and...
Comparable to peripheral vascular or interventional radiology segment revenues reported by diversified medical device manufacturers like Medtronic or Abbott Laboratories.
bsx_segment_peripheral_interventions_net_sales| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $473.00M | $452.00M | $462.00M | $465.00M | $478.00M | $479.00M | $477.00M | $503.00M | $535.00M | $538.00M | $534.00M | $573.00M | $590.00M | $602.00M | $645.00M | $656.00M | $698.00M | $702.00M |
| QoQ Change | — | -4.4% | +2.2% | +0.6% | +2.8% | +0.2% | -0.4% | +5.5% | +6.4% | +0.6% | -0.7% | +7.3% | +3.0% | +2.0% | +7.1% | +1.7% | +6.4% | +0.6% |
| YoY Change | — | — | — | — | +1.1% | +6.0% | +3.2% | +8.2% | +11.9% | +12.3% | +11.9% | +13.9% | +10.3% | +11.9% | +20.8% | +14.5% | +18.3% | +16.6% |